165 related articles for article (PubMed ID: 24219600)
1. The biodistribution of self-assembling protein nanoparticles shows they are promising vaccine platforms.
Yang Y; Neef T; Mittelholzer C; Garcia Garayoa E; Bläuenstein P; Schibli R; Aebi U; Burkhard P
J Nanobiotechnology; 2013 Nov; 11():36. PubMed ID: 24219600
[TBL] [Abstract][Full Text] [Related]
2. PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties.
Däpp S; García Garayoa E; Maes V; Brans L; Tourwé DA; Müller C; Schibli R
Nucl Med Biol; 2011 Oct; 38(7):997-1009. PubMed ID: 21982571
[TBL] [Abstract][Full Text] [Related]
3. New [99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors.
García Garayoa E; Schweinsberg C; Maes V; Rüegg D; Blanc A; Bläuenstein P; Tourwé DA; Beck-Sickinger AG; Schubiger PA
Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):42-50. PubMed ID: 17372572
[TBL] [Abstract][Full Text] [Related]
4. The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26.
Varasteh Z; Mitran B; Rosenström U; Velikyan I; Rosestedt M; Lindeberg G; Sörensen J; Larhed M; Tolmachev V; Orlova A
Nucl Med Biol; 2015 May; 42(5):446-454. PubMed ID: 25684649
[TBL] [Abstract][Full Text] [Related]
5. Intracellular CXCR4⁺ cell targeting with T22-empowered protein-only nanoparticles.
Unzueta U; Céspedes MV; Ferrer-Miralles N; Casanova I; Cedano J; Corchero JL; Domingo-Espín J; Villaverde A; Mangues R; Vázquez E
Int J Nanomedicine; 2012; 7():4533-44. PubMed ID: 22923991
[TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of bombesin peptide derivatives as potential tumor imaging agents: effects of structure and composition of amino acid sequence on in vitro and in vivo characteristics.
Okarvi SM; Jammaz IA
Nucl Med Biol; 2012 Aug; 39(6):795-804. PubMed ID: 22381782
[TBL] [Abstract][Full Text] [Related]
7. Comparison of [(11)C]Choline ([(11)C]CHO) and [(18)F]Bombesin (BAY 86-4367) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model.
Schwarzenböck SM; Schmeja P; Kurth J; Souvatzoglou M; Nawroth R; Treiber U; Kundt G; Berndt S; Graham K; Senekowitsch-Schmidtke R; Schwaiger M; Ziegler SI; Dinkelborg L; Wester HJ; Krause BJ
Mol Imaging Biol; 2016 Jun; 18(3):393-401. PubMed ID: 26483088
[TBL] [Abstract][Full Text] [Related]
8. Enhanced detection with spectral imaging fluorescence microscopy reveals tissue- and cell-type-specific compartmentalization of surface-modified polystyrene nanoparticles.
Kenesei K; Murali K; Czéh Á; Piella J; Puntes V; Madarász E
J Nanobiotechnology; 2016 Jul; 14(1):55. PubMed ID: 27388915
[TBL] [Abstract][Full Text] [Related]
9. Impact of surface grafting density of PEG macromolecules on dually fluorescent silica nanoparticles used for the in vivo imaging of subcutaneous tumors.
Adumeau L; Genevois C; Roudier L; Schatz C; Couillaud F; Mornet S
Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1587-1596. PubMed ID: 28179102
[TBL] [Abstract][Full Text] [Related]
10. Selection of optimal chelator improves the contrast of GRPR imaging using bombesin analogue RM26.
Mitran B; Varasteh Z; Selvaraju RK; Lindeberg G; Sörensen J; Larhed M; Tolmachev V; Rosenström U; Orlova A
Int J Oncol; 2016 May; 48(5):2124-34. PubMed ID: 26983776
[TBL] [Abstract][Full Text] [Related]
11. Tailored Dual PEGylation of Inorganic Porous Nanocarriers for Extremely Long Blood Circulation in Vivo.
Nissinen T; Näkki S; Laakso H; Kučiauskas D; Kaupinis A; Kettunen MI; Liimatainen T; Hyvönen M; Valius M; Gröhn O; Lehto VP
ACS Appl Mater Interfaces; 2016 Dec; 8(48):32723-32731. PubMed ID: 27934159
[TBL] [Abstract][Full Text] [Related]
12. Gastrin-releasing peptide receptor-targeted gadolinium oxide-based multifunctional nanoparticles for dual magnetic resonance/fluorescent molecular imaging of prostate cancer.
Cui D; Lu X; Yan C; Liu X; Hou M; Xia Q; Xu Y; Liu R
Int J Nanomedicine; 2017; 12():6787-6797. PubMed ID: 28979118
[TBL] [Abstract][Full Text] [Related]
13. Paradox of PEGylation in fabricating hybrid nanoparticle-based nicotine vaccines.
Hu Y; Zhao Z; Harmon T; Pentel PR; Ehrich M; Zhang C
Biomaterials; 2018 Nov; 182():72-81. PubMed ID: 30107271
[TBL] [Abstract][Full Text] [Related]
14. Intravital imaging of human prostate cancer using viral nanoparticles targeted to gastrin-releasing Peptide receptors.
Steinmetz NF; Ablack AL; Hickey JL; Ablack J; Manocha B; Mymryk JS; Luyt LG; Lewis JD
Small; 2011 Jun; 7(12):1664-72. PubMed ID: 21520408
[TBL] [Abstract][Full Text] [Related]
15. Tumor targeting and imaging with dual-peptide conjugated multifunctional liposomal nanoparticles.
Rangger C; Helbok A; Sosabowski J; Kremser C; Koehler G; Prassl R; Andreae F; Virgolini IJ; von Guggenberg E; Decristoforo C
Int J Nanomedicine; 2013; 8():4659-71. PubMed ID: 24353415
[TBL] [Abstract][Full Text] [Related]
16. Prevention of human PC-346C prostate cancer growth in mice by a xenogeneic tissue vaccine.
Suckow MA; Rosen ED; Wolter WR; Sailes V; Jeffrey R; Tenniswood M
Cancer Immunol Immunother; 2007 Aug; 56(8):1275-83. PubMed ID: 17242926
[TBL] [Abstract][Full Text] [Related]
17. Sorbitol as a Polar Pharmacological Modifier to Enhance the Hydrophilicity of
Giammei C; Balber T; Benčurová K; Cardinale J; Berroterán-Infante N; Brandt M; Jouini N; Hacker M; Mitterhauser M; Mindt TL
Molecules; 2020 Jun; 25(11):. PubMed ID: 32527027
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a technetium-99m labeled bombesin homodimer for GRPR imaging in prostate cancer.
Yu Z; Carlucci G; Ananias HJ; Dierckx RA; Liu S; Helfrich W; Wang F; de Jong IJ; Elsinga PH
Amino Acids; 2013 Feb; 44(2):543-53. PubMed ID: 22833158
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive study of the drug delivery properties of poly(l-lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice.
Shalgunov V; Zaytseva-Zotova D; Zintchenko A; Levada T; Shilov Y; Andreyev D; Dzhumashev D; Metelkin E; Urusova A; Demin O; McDonnell K; Troiano G; Zale S; Safarovа E
J Control Release; 2017 Sep; 261():31-42. PubMed ID: 28611009
[TBL] [Abstract][Full Text] [Related]
20. A cytomegalovirus-based vaccine expressing a single tumor-specific CD8+ T-cell epitope delays tumor growth in a murine model of prostate cancer.
Klyushnenkova EN; Kouiavskaia DV; Parkins CJ; Caposio P; Botto S; Alexander RB; Jarvis MA
J Immunother; 2012 Jun; 35(5):390-9. PubMed ID: 22576344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
